Vitro, developer, global manufacturer and marketer of comprehensive cancer diagnosis and data integration solutions, announced today that it has appointed Biocare Medical, global leader in advanced staining and reagent solutions, as exclusive distributor of your new NeoPATH Pro instrument in the United States. NeoPATH Pro will be officially presented at the USCAP Annual Meeting 2025 not Boston, MA.
NeoPATH Pro is a high-performance platform with the ability to 42 slide, compatible with advanced immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH). Distribution agreement leverages Biocare Medical's extensive experience and established presence in advanced staining solutions, providing US laboratories. better local support, service and access to innovative diagnostic technology.
Luis de Luzuriaga, CEO of Biocare Medical, declared: “We are pleased that Vitro has selected Biocare Medical as the exclusive distributor of NeoPATH Pro in the United States. Our proven business excellence will ensure successful introduction and adoption of NeoPATH Pro in the US market, supporting laboratories in providing improved diagnostic services to patients. This appointment highlights our reputation for excellence and reinforces our commitment to bringing cutting-edge diagnostic solutions to laboratories across the country.”
Ferran Prat, CEO of Vitro, he added: “Choosing Biocare Medical as our exclusive distribution partner in the US. perfectly aligns with our strategy to effectively introduce NeoPATH Pro to the market. We look forward to the launch at USCAP 2025, trusting in Biocare's ability to deliver exceptional customer service and support.”
About Biocare Medical
Biocare Medical is a globally recognized leader in advanced staining solutions and reagents for immunohistochemistry., in situ hybridization and related diagnostic disciplines. Committed to innovation and quality, Biocare empowers pathologists and clinical laboratories around the world to deliver accurate diagnoses and improve patient outcomes. For more information, visit www.biocare.net.
About Vitro
Vitro is a global partner specialized in integrated solutions in cancer diagnosis, with more than 30 years of proven track record. Vitro is committed to offering diagnostic excellence for everyone. With a reputation for innovation, reliability and high performance capabilities, Vitro supports clinical laboratories in achieving exceptional diagnostic performance. For more information, visit www.vitro.bio.
